| Dr Charles P Theivagt, MD | |
|
2101 S Cynthia St, Plex A, Mcallen, TX 78503-1294 | |
| (956) 687-7896 | |
| (956) 994-9694 |
| Full Name | Dr Charles P Theivagt |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 21 Years |
| Location | 2101 S Cynthia St, Mcallen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396840682 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | M3764 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Valley Baptist Medical Center- Brownsville | Brownsville, TX | Hospital |
| Doctors Hospital At Renaissance | Edinburg, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Ear Nose And Throat Specialist Pa | 7719877521 | 9 |
News Archive
A text messaging intervention with education-related messages sent to parents increased influenza vaccination coverage compared with usual care in a traditionally hard-to-reach, low-income, urban, minority population of children and adolescents, although coverage overall remained low, according to a study in the April 25 issue of JAMA.
BIND Biosciences announced today that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of BIND-014 in cancer patients. BIND-014, the first product candidate to enter clinical evaluation from BIND's broad proprietary Medicinal Nanoengineering platform, is a targeted polymeric nanoparticle containing the cytotoxic agent, docetaxel.
The Transplant Research and Education Center, housed at the Terasaki Research Institute for Biomedical Innovation (TIBI), launched the COVID-19 Kidney / Transplant Listening & Resource Center on June 17, 2020.
A group of researchers of the Imperial College of London headed by Professor Isaac Marks has published a randomized controlled study on internet-guided self-help for phobias and panic in the May-June issue of Psychotherapy and Psychosomatics.
› Verified 4 days ago
| Entity Name | Valley Ear Nose & Throat Specialist Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386648798 PECOS PAC ID: 7719877521 Enrollment ID: O20041119000824 |
News Archive
A text messaging intervention with education-related messages sent to parents increased influenza vaccination coverage compared with usual care in a traditionally hard-to-reach, low-income, urban, minority population of children and adolescents, although coverage overall remained low, according to a study in the April 25 issue of JAMA.
BIND Biosciences announced today that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of BIND-014 in cancer patients. BIND-014, the first product candidate to enter clinical evaluation from BIND's broad proprietary Medicinal Nanoengineering platform, is a targeted polymeric nanoparticle containing the cytotoxic agent, docetaxel.
The Transplant Research and Education Center, housed at the Terasaki Research Institute for Biomedical Innovation (TIBI), launched the COVID-19 Kidney / Transplant Listening & Resource Center on June 17, 2020.
A group of researchers of the Imperial College of London headed by Professor Isaac Marks has published a randomized controlled study on internet-guided self-help for phobias and panic in the May-June issue of Psychotherapy and Psychosomatics.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles P Theivagt, MD 2101 S Cynthia St, Plex A, Mcallen, TX 78503-1294 Ph: (956) 687-7896 | Dr Charles P Theivagt, MD 2101 S Cynthia St, Plex A, Mcallen, TX 78503-1294 Ph: (956) 687-7896 |
News Archive
A text messaging intervention with education-related messages sent to parents increased influenza vaccination coverage compared with usual care in a traditionally hard-to-reach, low-income, urban, minority population of children and adolescents, although coverage overall remained low, according to a study in the April 25 issue of JAMA.
BIND Biosciences announced today that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of BIND-014 in cancer patients. BIND-014, the first product candidate to enter clinical evaluation from BIND's broad proprietary Medicinal Nanoengineering platform, is a targeted polymeric nanoparticle containing the cytotoxic agent, docetaxel.
The Transplant Research and Education Center, housed at the Terasaki Research Institute for Biomedical Innovation (TIBI), launched the COVID-19 Kidney / Transplant Listening & Resource Center on June 17, 2020.
A group of researchers of the Imperial College of London headed by Professor Isaac Marks has published a randomized controlled study on internet-guided self-help for phobias and panic in the May-June issue of Psychotherapy and Psychosomatics.
› Verified 4 days ago
Melecio Jesus Medina, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1100 E Dove Ave Ste 402, Mcallen, TX 78504 Phone: 956-362-8125 Fax: 956-362-8135 | |
Dr. Ramiro Enrique Verdooren, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 801 E Nolana, Ste 1, Mcallen, TX 78504 Phone: 956-687-7796 Fax: 956-687-2308 | |
Sarah Chance Rodriguez, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1100 E Dove Ave Ste 402, Mcallen, TX 78504 Phone: 956-362-8125 Fax: 956-362-8135 | |
Alastair Glyn Lynn-macrae, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 S Cynthia St, Mcallen, TX 78503 Phone: 956-687-7896 Fax: 956-994-9694 | |
Dr. Tan Duong Nguyen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1100 E Dove Ave Ste 402, Mcallen, TX 78504 Phone: 956-362-8125 Fax: 956-362-8135 | |
Dr. John R. Austin, M.D., F.A.C.S. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2101 S Cynthia St, Mcallen, TX 78503 Phone: 956-687-7896 Fax: 956-687-2297 |